Course 4: Perinatal Alcohol, Stimulant, Cannabis and Nicotine Use

Course Overview

This video offers a comprehensive overview of perinatal substance use, focusing on alcohol, stimulants, cannabis, and nicotine. It provides clinicians with practical guidance on screening, assessment, and treatment,emphasizing a patient-centered approach. Participants will learn about guideline- recommended medications, and the challenges faced by perinatal individuals with substance use disorders. By the end of this video,clinicians will be equipped to provide effective and compassionate care to this vulnerable population.

Course Objectives

Identify the prevalence and risks associated with perinatal alcohol, stimulant, cannabis, and nicotine use.
Implement effective screening and assessment tools for perinatal substance use, including patient-centered approaches.
Provide guideline-recommended withdrawal management and long-term treatments for perinatal substance use, considering the unique needs of pregnant and postpartum individuals.
Incorporate counseling and support strategies into the treatment plan for perinatal substance use, addressing both the physical and psychological aspects of addiction.
Review the available medications for perinatal substance use treatment, considering their efficacy, safety, and potential side effects.
Address the specific concerns and challenges faced by perinatal individuals with substance use disorders, promoting a compassionate and supportive approach to care.
Collaborate with other healthcare providers, social workers, and community resources to provide comprehensive care for perinatal individuals with substance use disorders.

Target Audience

Clinicians and Staff of Birthing Hospitals

Includes Colorado Specific Information

Credit Information

Credit Type

* AMA PRA Category 1™

Number of Credits

* AMA PRA Category 1 ™ credits are used by physicians and other groups like PAs and certain nurses. Category 1 credits are accepted by the ARDMS, CCI, ACCME, and Sonography Canada.

Faculty

Kaylin Klie, MD, MA, FASAM Dr Kaylin Klie is a family medicine and addiction medicine physician at the University of Colorado and Denver Health. Her clinical focus is perinatal addiction which includes the care of families impacted by substance use. Dr Klie enjoys teaching students, residents, fellows, and the community about caring for people with substance use conditions. She is the program director of the Addiction Medicine Fellowship at the University of Colorado School of Medicine. She serves on various local, regional, and national committees dedicated to serving pregnant and parenting people with substance use.

Disclosure

Kaylin Klie discloses no such relationships exist

In compliance with the Essentials and Standards of the ACCME, the author of this CME tutorial is required to disclose any significant financial or other relationships they may have with commercial interests.

Estimated Time for Completion

1 hour

Date of Release

September 11th, 2024

Date of Most Recent Review

April 10th, 2025

Expiration Date

September 11th, 2027

Accreditation

Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Iowa Healthcare Collaborative (IHC) and Stader Opioid Consultants (SOC). The Iowa Healthcare Collaborative (IHC) is accredited by the IMS to provide continuing medical education for physicians. Designation: IHC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ Physicians should claim only the credit commensurate with the extent of their participation in the activity. Commercial Support: This activity was developed without support from any ineligible company. *The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company. Disclosure: IHC adheres to the Standards for Integrity and Independence in Accredited Continuing Education. The content of this activity is not related to products or the business lines of an ACCME-defined ineligible company. None of the planners or moderators for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing products used by or on patients. Note: We often receive questions about whether AMA PRA Category 1 Credits™ are accepted for nursing license renewal purposes. Please be informed that most state licensing boards across various disciplines nationwide recognize these credits as valid for continuing education. Many societies and credentialing bodies accept the AMA PRA Category 1 Credit™ as the top-tier continuing education credit and as an equivalent, provided the topic is relevant to the applicant’s field or discipline. After participating in our event, you will receive a Certificate of Attendance detailing the number of AMA PRA Category 1 Credits™ you can claim. This certificate does not automatically award continuing education credit, it is provided for self-reporting requirements and must be submitted to your respective state board for license renewal. We strongly recommend that each participant verify with their specific discipline’s licensing board to ensure acceptance of these credits. Thank you for your attention to this matter, and please feel free to reach out if you have further questions.

1 AMA PRA Category 1 Credit™